ArticleFrontiers in oncology2026
Sphincter-saving surgery versus abdominoperineal resection in low rectal cancer: the role of indocyanine green fluorescence angiography in surgical decision-making.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The choice between sphincter-saving surgery and abdominoperineal resection (APR) for low rectal cancer balances oncological radicality against functional preservation. Indocyanine green fluorescence angiography (ICG-FA) provides objective intraoperative assessment of bowel perfusion at the colonic stump, where ischemia is a leading cause of anastomotic failure. Materials and methods: In this prospective, single-center, descriptive cohort study (January 2021-December 2025) of more than 400 patients operated for colorectal cancer, 70 had low rectal cancer (≤6 cm from the anal verge) and 27 underwent sphincter-saving surgery - 7 intersphincteric resections, 4 immediate low colorectal or coloanal anastomoses, and 16 two-staged Turnbull-Cutait pull-through procedures. ICG-FA of the colonic stump was performed in 22 patients (81.5%), with proximal repositioning of the resection line whenever fluorescence was inadequate. Results: ICG-FA prompted modification of the resection line in 9 of 22 patients (40%), almost always proximally, but never altered the decision between sphincter preservation and APR. A radical (R0) resection was achieved in 19 of 21 patients with margin status recorded; two had an involved circumferential margin (R1), both in locally advanced node-positive tumors. Postoperative complications occurred in 15 of 27 patients (56%), mostly Clavien-Dindo grade I-II. There was no 30-day mortality; one late in-hospital death from an independent myocardial infarction occurred beyond 30 days. Conclusions: Sphincter-saving surgery for low rectal cancer is feasible but carries substantial morbidity. ICG-FA is a reproducible, low-risk adjunct that informs intraoperative decision-making; whether it reduces anastomotic complications requires confirmation in randomized studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.